Apple is such a secretive company that most of the time we don’t really know what they’re working on until they unveil a new product. The famous “And one more thing…” flourish that Steve Jobs perfected is their trademark, and it means that journalists reporting on upcoming launches have to interpret remarks and rumours, of which there are always plenty.

Apple has given strong hints that it's planning an Augmented Reality product #AR
Click To Tweet

In this article for iDrop News I attempt to piece together all the evidence I could find to try and build a picture of how Apple might be looking to get in on the Augmented/Mixed Reality market, following Tim Cook’s comments saying that the future of AR was bigger than VR.

Apple Is Secretly Developing Revolutionary VR & AR Technology, Here’s Everything We Know #applenews https://t.co/H5yOt21yQw via @iDropNews

— iDrop News (@iDropNews) November 30, 2016

The post The ARple of my i? How Apple Will Get Into Augmented Reality appeared first on Tecntrend.

Personalised healthcare is likely to transform the way we prevent and treat diseases in the future, specially as IoT and Wearables become increasingly pervasive.

Personalised healthcare will transform the way we prevent and treat diseases
Click To Tweet

With smart monitoring devices already integrating seamlessly into our routines, companies are now looking at the best way to harness the wealth of data that they collect for research purposes.

Tech companies are looking at ways to harness data for research purposes
Click To Tweet

Personalised medicine was worth over $1 billion in 2014 and the market is expected to double by 2022
Click To Tweet

Apple’s ResearchKit is one such initiative, giving researchers direct access to relevant data for their studies (daily step counts, heart rate, calorie use, etc.) and offering developers an open source framework that integrates seamlessly with HealthKit to allow them to create their own medical research apps.

Apple’s ResearchKit gives researchers direct access to relevant data for their studies
Click To Tweet

In the two years since its launch, the kit has already proven useful for clinical trials, with hundreds of thousands of people contributing data for studies ranging from diabetes to epilepsy, melanoma, asthma and breast cancer.

In the two years since its launch, the kit has already proven useful for clinical trials
Click To Tweet

It’s surprising that it has taken big pharma companies so long to get on board
Click To Tweet

It’s somewhat surprising, then, that it has taken big pharma companies so long to get on board. Recently, however, GlaxoSmithKline (GSK) announced that it was launching a new research app on the platform to help monitor rheumatoid arthritis patients.

GSK’s PARADE (Patient Rheumatoid Arthritis Data from the Real World) study aims to tackle this debilitating disease by learning from patient insights and therapeutic goals. They are currently seeking volunteers (aged over 21 and diagnosed with RA) to monitor their health and share those insights into how RA affects their lives.

The GSK study will collect data from Rheumatoid Arthritis patients using iPhone sensors
Click To Tweet

This data will be collected through a mixture of surveys and iPhone sensors which will track common RA symptoms such as fatigue, joint pain and overall mood. The study will not provide diagnosis or treatment, but will allow patients to view their own study data and learn more about their condition.

The PARADE study will track 300 patients over a three-month period
Click To Tweet

The study will track 300 patients over a three-month period. GSK believes that collecting data from mobile devices in this way will in future help to alleviate the burden on patients by reducing the need for frequent doctor visits during clinical studies. More broadly, as sensors – and even implants – become increasingly sophisticated, doctors will be able to accurately monitor patient progress continuously and much more efficiently, with minimum intrusion upon their daily routine.

The prospects are exciting, not only from a quality of life perspective, but considering the personalized medicine market was valued at over USD 1 billion in 2014 and is expected to more than double by 2022.

The post Will Apple’s ResearchKit Be a Game Changer for HealthTech? appeared first on Tecntrend.